Señales en vivo de VBS.AX | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 may 2024 @ 20:31):

Stats
Volumen de hoy	5 360.00
Volumen promedio	7 814.00
Capitalización de mercado	12.50M
EPS	$0 ( 2024-02-21 )
Próxima fecha de ganancias	( $0 ) 2024-07-25
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-5.87
ATR14	$0 (0.00%)

Vectus Biosystems Limited Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Vectus Biosystems Limited Finanzas

Annual	2023
Ingresos:	$1.35M
Beneficio Bruto:	$1.31M (96.51 %)
EPS:	$-0.0719

FY	2023
Ingresos:	$1.35M
Beneficio Bruto:	$1.31M (96.51 %)
EPS:	$-0.0719

FY	2022
Ingresos:	$1.30M
Beneficio Bruto:	$1.28M (98.45 %)
EPS:	$-0.120

FY	2021
Ingresos:	$180.00
Beneficio Bruto:	$180.00 (100.00 %)
EPS:	$-0.183

Financial Reports:

No articles found.

Vectus Biosystems Limited

Vectus Biosystems Limited engages in the medical research and development activities in Australia. The company develops treatment for fibrosis and high blood pressure, which include treatments for heart, kidney, liver, and lung diseases. Its lead compound is VB0004, which is aimed at treating the loss of functional tissue to fibrosis, scarring, and high blood pressure. The company also intends to develop candidates for the treatment of fibrotic liver diseases, including non-alcoholic steatohepatitis and pulmonary fibrotic diseases. In addition, it develops AccuCal and RealCount software that enhance speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories. The company was incorporated in 2005 and is based in Rosebery, Australia.